Sanofi and GSK join forces to fight COVID-19

Sanofi and GSK announced on 14 April 2020 that they will work together on the development of a new, adjuvanted vaccine for COVID-19. The collaboration for the first time brings together the scientific and manufacturing expertise and resources of two global scale vaccines specialists to address the urgent global need for a vaccine to protect people from this disease.

Source: GSK

Tags:

COVID-19

Nicole Verbeeck

Nicole Verbeeck is Founder and Editor-in-Chief of Moonshot for Life, covering global health progress. She is also founder of Juneau Cayenne, a creative design, content and technology lab crafting innovative storytelling experiences for clients in healthcare and life sciences worldwide and she is a healthy food chef focusing on prevention of disease.